Stiripentol, sold under the brand name Diacomit, is an anticonvulsant medication used for the treatment of Dravet syndrome - a serious genetic brain disorder. [5] [6]

DIACOMIT (stiripentol) is FDA approved to treat Dravet seizures in patients 6 months and older (15 lb or more) on clobazam. See full safety and PI.

2024年9月9日 · Diacomit (stiripentol) is an oral anticonvulsant used with clobazam (Onfi) for seizures associated with Dravet syndrome in patients 6 months of age and older, weighing at least 7 kg (15.4 lbs), and taking the benzodiazepine clobazam (Onfi).

2023年10月16日 · Stiripentol (stir-ih-PEN-tol) is the generic name (non-brand name) of a seizure medicine with the brand name Diacomit® from Biocodex. In the US, the FDA has approved stiripentol in combination with clobazam (Onfi) to treat seizures associated with Dravet syndrome in persons 6 months of age and older.

2025年3月1日 · Stiripentol is used with clobazam to treat seizures in patients with Dravet syndrome. This medicine is available only with your doctor's prescription.

Stiripentol is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement activity in the brain. How should this medicine be used?

Stiripentol is used with other medications to treat a certain inherited seizure disorder (Dravet syndrome). It belongs to a class of drugs known as anticonvulsants.

2024年12月31日 · Detailed drug Information for Stiripentol. Includes common brand names, drug descriptions, warnings, side effects and dosing information.

View stiripentol information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, contra-indications and monitoring requirements.

Stiripentol (STIR i PEN tol) has been approved by the FDA to treat seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. Who should not take stiripentol? Your epilepsy treatment should always be …